22 May, 12:09 - Indian

SENSEX 80821.46 (-0.95)

Nifty 50 24594.7 (-0.88)

Nifty Bank 54674.6 (-0.73)

Nifty IT 37102.7 (-1.17)

Nifty Midcap 100 56321.05 (-0.53)

Nifty Next 50 66774.55 (-0.25)

Nifty Pharma 21543.75 (-0.83)

Nifty Smallcap 100 17515.5 (-0.19)

22 May, 12:09 - Global

NIKKEI 225 36985.87 (-0.84)

HANG SENG 23548.11 (-1.17)

S&P 5880.75 (0.13)


Hot Pursuit News

You are Here : Home > News > Hot Pursuit News >

(24 Dec 2024, 15:07)

Kwality Pharma gains on securing SAHPRA approval for Tamoxifen tablet

Kwality Pharmaceuticals rose 1.95% to Rs 897 after the company announced that it has successfully obtained product approval for its Tamoxifen Tablet from the South African Health Products Regulatory Authority (SAHPRA).


The approval was granted through a site transfer process for the company's prominent oncology oral solid dosage (OSD) product.

This approval is a significant achievement in expanding the availability of this critical therapeutic, which plays a vital role in the treatment of hormone receptor-positive breast cancer. It reflects its ongoing commitment to providing high-quality, accessible oncology treatments to patients in key markets.

The firm said, “This approval further strengthens our presence in the High Regulated and global oncology market.”

Kwality Pharmaceuticals is engaged in the business of manufacturers, buyers and sellers of and dealers in all kind of drugs intermediates, chemicals, extracts, alkaloids and other pharmaceutical goods, toilet requisites, medicines, beverages and other medical preparations.

The company’s consolidated net profit surged 35.7% to Rs 8.47 crore on 29.3% jump in net sales to Rs 90.03 crore in Q2 FY25 over Q2 FY24.

More News
More Company News View Company Information

Capital Market Publishers India Pvt. Ltd

401, Swastik Chambers, Sion Trombay Road, Chembur, Mumbai - 400 071, India.

Formed in 1986, Capital Market Publishers India Pvt Ltd pioneered corporate databases and stock market magazine in India. Today Capitaline corporate database cover more than 35,000 listed and unlisted Indian companies. Latest technologies and standards are constantly being adopted to keep the database user-friendly, comprehensive and up-to-date.

Over the years the scope of the databases has enlarged to cover economy, sectors, mutual funds, commodities and news. Many innovative online and offline applications of these databases have been developed to meet various common as well as customized requirements.

While all the leading institutional investors use Capitaline databases, Capital Market magazine gives access to the databases to individual investors through Corporate Scoreboard. Besides stock market and company-related articles, the magazine’s independent and insightful coverage includes mutual funds, taxation, commodities and personal finance.

Copyright @ Capital Market Publishers India Pvt.Ltd

Designed, Developed and maintained by CMOTS Infotech (ISO 9001:2015 Certified)

Site best viewed in Internet Explorer Edge ,   Google Chrome 115.0.5790.111 + ,   Mozilla Firefox 115.0.3 + ,   Opera 30.0+, Safari 16.4.1 +